Skip to content

Alkermes plc.

ALKS· NasdaqCore metricsCIK 1520262

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -1.90%
Market cap
$7.89B
168.04M shares
Filings
1,062
$480.13M
Q3 2026−5.2% FY25 yoy
$16.29M
Q3 2026−34.2% FY25 yoy
$36.02M
Q3 2026−39.6% FY25 yoy
$57.28M
Q3 2026derived+18.4% FY25 yoy
$0.09
Q3 2026−34.1% FY25 yoy
$631.31M
Q3 2026+33.5% FY25 yoy
$7.89B
—
4.5×
4.2×
2.88%
—

Twelve months to Sep 30, 2026 · derived

Price

$46.97+38.94%+$13.17past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$1.48BFY 2025
$1.66B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$1,475,899,000reported
FY 20242024-12-31$1,557,632,000reported
FY 20232023-12-31$1,663,405,000reported
FY 20222022-12-31$1,111,795,000reported
FY 20212021-12-31$1,173,751,000reported
FY 20202020-12-31$1,038,756,000reported
FY 20192019-12-31$1,170,947,000reported
FY 20182018-12-31$1,094,274,000reported
FY 20172017-12-31$903,374,000reported
FY 20162016-12-31$745,694,000reported
FY 20152015-12-31$628,335,000reported
FY 20142014-12-31$618,789,000reported

Capital returns

Dividends and buybacks · FY2009 to FY2024
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2024—$200.28M$200.28M—162.61M sh−2.7%49.4%
FY2009—$2.68M$2.68M————

Segments

Revenue by Geography, FY2018 to FY2025FY2018U.S. · FY2018 · $884.60MRest of world · FY2018 · $204.76MIreland · FY2018 · $4.92MFY2019U.S. · FY2019 · $966.93MRest of world · FY2019 · $200.82MIreland · FY2019 · $3.20MFY2020U.S. · FY2020 · $839.00MRest of world · FY2020 · $196.53MIreland · FY2020 · $3.23MFY2021U.S. · FY2021 · $984.24MRest of world · FY2021 · $187.34MIreland · FY2021 · $2.18MFY2022U.S. · FY2022 · $931.99MRest of world · FY2022 · $177.98MIreland · FY2022 · $1.83MFY2023U.S. · FY2023 · $1.49BRest of world · FY2023 · $170.29MIreland · FY2023 · $1.18MFY2024U.S. · FY2024 · $1.41BRest of world · FY2024 · $146.18MIreland · FY2024 · $1.29MFY2025U.S. · FY2025 · $1.37BRest of world · FY2025 · $102.36MIreland · FY2025 · $754.00K
LineFY2025ShareChange
U.S.$1.37B93%−2.7%
Rest of world$102.36M6.9%−30.0%
Ireland$754.00K0.1%−41.7%
Total$1.48B

From the 10-K filed Feb 25, 2026ALKS

Pharmaceutical preparations

Alkermes plc. is the 30th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Alkermes plc. · CIK 1520262 · Engraved from SEC EDGAR